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Abstract Depending on the concentration, Mn can exert
protective or toxic effect. Potential mechanism for man-
ganese neurotoxicity is manganese-induced oxidative
stress. Glutamine supplementation could reduce man-
ganese-induced neurotoxicity and is able to influence the
neurotransmission processes. The aim of this study was to
investigate whether the long term administration of man-
ganese (alone or in combination with glutamine) in dose
and time dependent manner could affect the selected
parameters of oxidative-antioxidative status (superoxide
dismutase and glutathione peroxidase activities, concen-
trations of vitamin C and malonic dialdehyde) and con-
centrations of excitatory (Asp, Glu) and inhibitory amino
acids (GABA, Gly) in the brain of rats. The experiments
were carried out on 2-months-old albino male rats ran-
domly divided into 6 group: Mn300 and Mn500—received
solution of MnCl2 to drink (dose 300 and 500 mg/L,
respectively), Gln group—solution of glutamine (4 g/L),
Mn300-Gln and Mn500-Gln groups—solution of Mn at
300 and 500 mg/L and Gln at 4 g/L dose. The control
group (C) received deionized water. Half of the animals
were euthanized after three and the other half—after
6 weeks of experiment. The exposure of rats to Mn in
drinking water contributes to diminishing of the antioxi-
dant enzymes activity and the increase in level of lipid
peroxidation. Glutamine in the diet admittedly increases
SOD and GPx activity, but it is unable to restore the
intracellular redox balance. The most significant
differences in the examined amino acids levels in com-
parison to both control and Gln group were observed in the
group of rats receiving Mn at 500 mg/L dose alone or with
Gln. It seems that Gln is amino acid which could improve
antioxidant status and affect the concentrations of the
neurotransmitters.
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Introduction
Manganese (Mn) is an essential trace element for humans,
animals and plants. It is required for normal growth,
development and cellular homeostasis [1]. Mn participates
in numerous enzymatic reactions, including the synthesis
of amino acids, proteins, lipids and carbohydrates [2].
Additionally, this element is necessary for normal immune
function, adenosine triphosphate (ATP) regulation, bone
growth and digestion. Mn is the constituent of metalloen-
zymes such as manganese superoxide dismutase (Mn-
SOD), arginase, pyruvate decarboxylase and glutamine
synthetase (GS) [3].
Even though Mn is an element necessary for the proper
functioning of cells and tissues in the body, its overabun-
dance contributes to the pathophysiological processes of the
central nervous system (CNS) [4]. Excessive Mn accumu-
lation most prominently in the basal ganglia (globus pallidus,
substantia nigra, subthalamic nuclei, caudate putamen) and
in cortical structures, causes toxic effects and neurological
brain disorder, referred to as manganism [5–7].
The biochemical mechanism responsible for Mn
induced neurotoxicity (due to excessive Mn exposure) is
still not fully elucidated. However, a potential mechanism
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for manganese neurotoxicity is manganese-induced oxida-
tive stress, thereby leading to excessive production of
reactive oxygen species (ROS). The ROS generate the
oxidation of polyunsaturated fatty acids of the cell mem-
brane, leading to its damage and consequently to cell death.
Disturbing the pro-antioxidative balance in the organism is
manifested by reduced activity of some antioxidant
enzymes, inter alia, in the brain. Diminishing of ascorbic
acid concentrations, whose presence within neurons and
astrocytes in specific and efficient transporters, may also
occur [8, 9]. Furthermore the manganese-induced ROS
overproduction could affect the brain glucose metabo-
lism—Mn can easily inhibit GS activity—one of the
astrocytic-specific enzyme. The consequence of this pro-
cess could be the enhanced biosynthesis of neurotrans-
mitters such as glutamate (Glu), aspartate (Asp) and
c-amino butyric acid (GABA) [10, 11].
Glutamine (Gln) is the two-thirds amino acid in the
brain. It plays an important role as a precursor of the
neurotransmitter amino acids, including the excitatory Glu
and Asp, and the inhibitory GABA and glycine (Gly).
Glutamine is considered as an amino acid of conditional
essentiality during certain diseases, where the demand for
Gln outstrips its synthesis from endogenous precursors [12,
13]. Gln is required during catabolic processes to elicit
optimal tissue responses to infection, inflammation and
catabolism. Moreover, some researchers suggest that Gln
metabolites can prevent against hydroxyl-radical apoptosis
in animal erythrocytes [14]. Recently, Robinson et al. [15]
showed that GS activity can be affected by hydrogen per-
oxide, providing the clear link between the occurrence of
oxidative stress and glutamine synthesis.
We hypothesised that Gln supplementation could reduce
manganese-induced oxidative stress and could influence
the neurotransmission processes. The aim of this study was
to investigate whether the long term administration of
manganese (alone or in combination with glutamine) in
dose and time dependent manner could affect the selected
parameters of oxidative-antioxidative status as concentra-
tions of malonic dialdehyde (MDA) and ascorbic acid
(vitamin C) as well as the activity of antioxidant
enzymes—superoxide dismutase (SOD) and glutathione
peroxidase (GPx) in the brain of rats. Moreover, concen-
trations of excitatory (Glu, Asp) and inhibitory (GABA,
Gly) amino acids were also determined.
Materials and Methods
Reagents
Kits for GPx Ransel and SOD (RANSOD) were obtained
from Randox Laboratories Ltd., UK.
Reagents for amino acid analysis: ninhydrin, hydrin-
dantin, 2-methoxyethanol, 4 M acetate buffer pH 5.6 and
standards: physiological and glutamine were purchased
from INGOS, Czech Republic. Citric acid monohydrate,
lithium citrate tetrahydrate, lithium chloride and sodium
azide were from Merck, Germany.
Manganese chloride and L-ascorbic acid were obtained
Sigma Chemicals, USA. L-glutamine was obtained from
POCH S.A. (Acros Organics), Poland.
All other reagents were of analytical grade and were
provided by commercial suppliers.
Experimental Design and Sampling Procedure
The experiments were carried out on 2-months-old albino
male rats (Farm of Laboratory Animals, Warszawa, Poland)
weighing 220–250 g at the beginning of the experiment. The
animals were maintained under standard laboratory condi-
tions (12 h light/dark cycle, room temperature 21 ± 1 C)
with free access to tap water as well as laboratory chow
(Bacutil, Motycz, Poland), and were adapted to the labora-
tory conditions for at least 1 week. The study was carried out
according to the National Institute of Health Guidelines for
the Care and Use of Laboratory Animals and to the European
Community Council Directive for the Care and Use of
Laboratory Animals of 24 November 1986 (86/609/EEC),
and was approved by the Local Ethics Committee on Animal
Experimentation. All the animals were randomly divided
into six groups (12 animals per each experimental group).
The first five groups received deionised water, to which Mn
or/and Gln was added; 1st group (Mn300)—solution of
manganese chloride at a concentration of 300 mg Mn/L, 2nd
group (Mn500)– solution of manganese chloride at a con-
centration of 500 mg Mn/L, 3rd group (Gln)—solution of
glutamine at a concentration of 4 g/L, 4th group (Mn300-
Gln)—solution of Mn at a concentration of 300 mg/L and
4 g Gln/L, and 5th (Mn500-Gln)—solution of Mn at a con-
centration of 500 mg/L and 4 g Gln/L. The 6th group—
control (C) received deionised water to drink in a daily
manner. All the animals were fed with the same standard
granulated rodent laboratory chow (Poland). Diet and fluids
were offered ad libitum and their consumption was moni-
tored daily over the experimental period.
The study period covered 6 weeks. Half of the animals
(n = 6) of each group were intraperitoneally injected with
0.5 mL of 5 % ketamine after first 3 weeks. The remaining
animals were euthanized after further 3 weeks. Before the
euthanasia, all animals were fasting for 12 h, thus the last
meal consumed by the experimental rats had no effect on
results. After euthanasia the whole brain was removed and
kept in -25 C until amino acid analysis. The character-
istic of study and control groups with statistical analysis is
presented in Table 1.
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Ion-Exchange Analysis of Amino Acid
Concentrations in Rats’ Brain
To evaluate free amino acids concentration, six left and six
right hemispheres from each group were homogenised and
deproteinised in 6 % sulphosalicylic acid in lithium citrate
buffer (pH 2.8) in 1:10 ratio. The homogenised samples
were centrifuged 20 min at 12,000 rpm. The obtained
supernatants were used for free amino acids determination
with the use of ion-exchange chromatography [16] on an
INGOS AAA 400 apparatus for automatic analysis of
amino acids (Ingos Corp., Czech Republic). Amino acids
were separated using analytic column OSTION LG FA
(Ingos Corp., Czech Republic) and five lithium-citrate
buffers (pH 2.6, 3.1, 3.35, 4.05 and 4.65, respectively). For
amino acids evaluation was used the original software
MIKRO version 1.8.0. (Ingos Corp., Czech Republic).
Determination of Antioxidants in Rats’ Brain
Remaining hemispheres (six left and six right hemispheres)
were homogenised in 0.1 mol/L Tris–HCl buffer (pH 7.4)
in 1:10 ratio. The homogenised sample was centrifuged at
12000 rpm for 30 min at 4 C. The supernatants were used
for GPx, SOD, MDA and L-ascorbic acid determination.
GPx activity was determined by Paglia and Valentine
method [17]. GPx catalyzes the process of glutathione
(GSH) oxidation by cumene hydroperoxide. In the pres-
ence of glutathione reductase (GR) and NADPH the oxi-
dized glutathione (GSSG) is immediately converted to the
reduced form with a concomitant oxidation of NADPH to
NADP?. GPx activity was expressed in units per gram of
tissue (U/g of tissue).
SOD activity was determined according by Fridovitch
and McCord method [18]. The method employs xantine
and xantine oxidase (XOD) to generate superoxide radicals
which react with nitroblue tetrazolium to form red for-
mazan dye. The SOD activity is then measured by the
degree of inhibition of the reaction. The enzyme activity in
brain homogenates was expressed in units per gram of
tissue(U/g of tissue) as a total SOD activity (the activity of
all isoforms of this enzyme).
The ascorbic acid concentration in the rat brain was
determined according to modified Kyaw’s method [19].
The basis of the method is the reduction of phosphotungstic
acid by ascorbic acid from examined samples. The mea-
surement of absorbance of the samples (blue tungstic oxide
is formed—colloids of tungstic oxides) at 700 nm allows to
calculate the concentration of ascorbic acid brain homo-
genates. The results were expressed in lmol/g of tissue.
Table 1 Body weight gain as well as intake of diet and water/fluids in the tested animals groups
Group C Gln Mn500 Mn300 Mn500-Gln Mn300-Gln
Parameter
After 3 weeks
Initial body weight (g) 222.0 ± 7.4 227.8 ± 8.1 235.8 ± 8.4 227.8 ± 14.3 235.6 ± 9.4 236.8 ± 14.0
Body weight after 3 weeks (g) 334.8 ± 16.4 325.8 ± 13.1 354.8 ± 15.4 325.3 ± 21.4 307.3 ± 13.6^ 323.2 ± 17.2
Body weight gain (g) 112.8 ± 11.9 98.0 ± 10.6 119.0 ± 11.9 97.5 ± 17.9 71.6 ± 11.5*,^ 86.4 ± 15.6
Food (g/rat/24 h) 28.4 ± 2.6 25.8 ± 3.4 29.8 ± 2.4 27.4 ± 3.4 24.8 ± 4.2 26.2 ± 2.2
Fluid (ml/rat/24 h) 42.8 ± 1.8^ 36.7 ± 2.1* 43.0 ± 1.4 43.5 ± 1.2 37.4 ± 1.3^,* 39.4 ± 1.9
Mn (mg/rat/24 h) – – 24.1 ± 1.4 13.1 ± 1.7^^^ 18.7 ± 2.2^ 11.8 ± 1.8 ^^^,*
Gln (mg/rat/24 h) – 146.8 ± 12.8 – – 149.6 ± 14.8 157.6 ± 8.4
After 6 weeks
Initial body weight (g) 218.7 ± 6.3 230.7 ± 9.6 240.0 ± 10.2 223.3 ± 11.3 234.0 ± 9.1 244.0 ± 17.1
Body weight after 6 weeks (g) 358.7 ± 10.7 358.6 ± 11.6 386.6 ± 12.8 335.6 ± 15.3^^ 335.6 ± 11.4^^ 355.8 ± 16.8
Body weight gain (g) 140.0 ± 8.5^ 127.9 ± 10.6 146.6 ± 11.6 112.3 ± 13.4^ 101.6 ± 10.2^^,* 111.8 ± 17.0
Food (g/rat/24 h) 27.4 ± 2.8 26.5 ± 2.2 29.9 ± 1.2 25.4 ± 3.1 23.6 ± 3.2 26.1 ± 3.8
Fluid (ml/rat/24 h) 44.6 ± 1.1 34.8 ± 1.8*** 48.1 ± 2.8### 40.3 ± 1.2#,^^ 38.2 ± 1.2**,^^^ 38.9 ± 1.5*
Mn (mg/rat/24 h) – – 24.1 ± 1.2 12.1 ± 0.9^^^ 19.1 ± 1.3^^ 11.7 ± 0.7***
Gln (mg/rat/24 h) – 139.2 ± 12.1 – – 152.8 ± 11.6 155.6 ± 10.8
Data expressed as a mean ± SD
* significant different versus control group (* p\ 0.05; ** p\ 0.01; *** p\ 0.001)
# significant different versus Gln group (# p\ 0.05; ### p\ 0.001)
^ significant different versus Mn500 group (^ p\ 0.05; ^^ p\ 0.01; ^^^ p\ 0.001)
* significant different versus Mn500_Gln group (* p\ 0.05; *** p\ 0.001)
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The level of lipid peroxidation (LPO) was assayed in
terms of MDA concentration which is the main product of
this process. It was determined according to Ledwo _zyw’s
method [20]. Briefly, 0.5 ml of tissue homogenate super-
natant was mixed with 2.5 mL 1.22 M trichloroacetic acid
(TCA) in 0.6 M HCl and allowed to stand for 15 min. Then
1.5 mL of 0.9 % thiobarbituric acid (TBA) was added and
the mixture was incubated for 30 min in a boiling water
bath. After cooling of 4 ml of n-butanol was added and the
mixture was shaken variously. The samples were cen-
trifuged at 1500 g for 10 min and then the absorbance
of organic phase was measured with respect to blank
(n-butanol alone). The concentrations of MDA in brain
tissues were read from the standard curve obtained by
using malonaldehyde bis-dimethylacetal and expressed in
lmol/g of tissue.
The assays were performed using spectrophotometer
HITACHI 2800 (Japan).
Statistical Analysis
All statistical analyses were performed using STATIS-
TICA program (version 10.0). The data were expressed as
the medians of measured parameters. Shapiro–Wilk’s test
was used to verify normality of data distribution and
Brown–Forythe’s test to determine homogeneity of vari-
ances. Differences between groups were analyzed with
Kruskal–Wallis one-way analysis of variances and analysis
of variance (ANOVA) for multi-group comparison with
post hoc Tukey’s test. For all analyses, p values \0.05
(p\ 0.05) were considered as significant.
Results
Brain Tissue Glutamine Analysis
After 3 weeks of experiment, glutamine concentration was
statistically higher in the group of rats receiving only
glutamine (Gln) in comparison to all other tested groups
(C, Mn300, Mn500, Mn300-Gln, Mn500-Gln). Whereas,
after 6 weeks of the experiment, glutamine levels were
statistically higher in Gln group in comparison only to the
control (C) and Mn300-Gln group (Fig. 1).
Brain Tissues Oxidative-Antioxidative Status
Parameters
The exposure of rats to Mn in drinking water contributes to
diminishing of the antioxidant enzymes activity and the
increase of the level of lipid peroxidation. GPx activity
after 3 weeks of the experiment was significantly lower in
rats receiving Mn at 500 mg/L dose in comparison to
control group (C) and the group receiving only glutamine
(Gln). However, after longer exposure time (6 weeks), the
activity of this enzyme was diminished in both groups of
rats receiving the manganese (Mn300 and Mn500) com-
pared only to the control (C).
SOD activity in both stages of the experiment was
decreased in the groups of rats receiving the manganese at
500 mg/L dose (either alone or in combination with glu-
tamine—Mn500, Mn500-Gln) in comparison to the control
and Gln groups.
Fig. 1 Concentration of glutamine in rats’ brains after 3 and 6 weeks of exposure to manganese and/or glutamine. Values presented as the
median, minimum and maximum of examined parameters
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The exposure of organisms to manganese appears to be the
cause of increased lipid peroxidation, which is confirmed by an
increased concentration of one of the indicators of this process
–malondialdehyde. The level of this parameter was markedly
higher in the group of rats receiving manganese at 500 mg/L
dose in comparison to the control (C) after 3 and 6 weeks of the
experiment and to the group of rats receiving only the glu-
tamine (Gln) after 3 weeks. In addition, after 6 weeks, the
concentration of MDA in Mn500 group was statistically
higher than in the groups receiving both doses of manganese in
combination with glutamine (Mn300-Gln and Mn500-Gln),
which can indicate the protective influence of glutamine.
However, statistical analysis showed no distinct differ-
ence in vitamin C concentration between examined groups
at both stages of the experiment.
Effect of manganese and/or glutamine on oxidative-an-
tioxidative status parameters in rats’ brain after 3 and
6 weeks of experiment was presented in Fig. 2.
Brain Tissues Amino Acid Analysis
The most significant differences in examined amino acids
levels in comparison to both control and Gln group were
observed in the group of rats receiving Mn at 500 mg/L
dose alone or with Gln.
Glu concentration was markedly increased in group
receiving manganese at 500 mg/L after 6 weeks-long
exposure. The obtained values were statistically different in
comparison with both control and Gln-given groups.
Asp concentration was insignificantly increased in rats
receiving manganese at 500 mg/L dose for 6 weeks versus
groups of rats receiving manganese in combination with
glutamine (Mn300-Gln and Mn-500-Gln).
GABA concentration values were significantly lower in
Mn500 group compared to the Gln group, both after 3 and
6 weeks of experiment. Moreover, the level of this parameter
was significantly decreased in groups of rats receiving Mn in
both doses for 3 weeks versus groups receiving Mn plus Gln.
After 6 weeks this difference was noticed only in the rats
receiving manganese at higher dose.
Gly concentration was significantly increased in brain of
rats receiving manganese at higher dose of Mn, both alone
and in combination with Gln. The difference between these
groups (Mn500 and Mn500-Gln) and groups: control and
receiving Gln alone was observed after 3 weeks of exper-
iment. After 6 weeks-long exposure only a slightly differ-
ence between groups receiving manganese at 500 mg/L
dose (alone or with Gln) and the control group was noticed.
The effect of manganese and/or glutamine on excitatory
(Glu, Asp) and inhibitory (GABA, Gly) neurotransmitter
amino acids concentrations in rats’ brain after 3 and
6 weeks of experiment is presented in Fig. 3.
Discussion
Brain Tissues Oxidative-Antioxidative Status
Parameters
Manganese is an essential element for the proper course of
many enzymatic reactions. However, depending on the
concentration, Mn can exert protective or toxic effect.
Moreover, it could be a scavenger of superoxides or induce
their production, which in consequence may disrupt the
antioxidant system. Excessively high systemic exposure to
manganese has been recognized as neurotoxic. Patho-
physiology of Mn-associated neurotoxicity was observed in
mammals in both the acute and chronic exposures [21, 22].
Available data demonstrated that Mn exposure stimulated
generation of ROS and induced a decrease in the activity of
SOD and GPx [2, 23–29], but the mechanism of this pro-
cess is still not fully elucidated.
In the present study, statistically lower SOD activity in
the group of rats receiving higher Mn dose, regardless the
duration of the experiment, was observed. Glutamine in the
diet admittedly increases SOD activity, but it is unable to
restore the intracellular redox balance. On the other hand,
GPx activity also depends on the dose and the duration of
Mn exposure. After 3 weeks, a higher dose of Mn dimin-
ished the GPx activity, while longer exposure contributes
to the reduction of this enzyme activity even at lower doses
of the metal. Glutamine administered in the diet contributes
to establishing the status of the balance, regardless of the
time of exposure and the applied dose of Mn.
In the available studies there is no information about the
interaction of glutamine and manganese administered in the
diet and the mechanism according to which glutamine could
protect against Mn-induced toxicity. However, Roth et al.
[30] showed that Gln is the precursor for the synthesis of
GSH and presented significant correlation between Gln
supplementation and intercellular GSH content. Therefore,
we suppose that glutamine may increase the GPx activity in
the brain of rats exposed to Mn by providing an
energy source and by acting as precursor of glutathione.
Furthermore, our findings are consistent with the results of
other researchers according to which the Gln supplementa-
tion enhances antioxidant capacity in various diseases [2,
31–35].
Noteworthy is that excessive O2
2 and H2O2 production,
and consequently increased HO expression, may result in
the lipid peroxidation (LPO). In vitro studies [7, 36] indi-
cated that the increase in LPO and depletion of high energy
phosphates are the first factors indicating the astrocyte and
neuronal dysfunction caused by Mn. In our research LPO
was determined by measuring MDA concentration. We
noticed that the peroxidation process occurs in groups of
Neurochem Res (2016) 41:2129–2139 2133
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Fig. 2 Effect of manganese and/or glutamine on chosen parameters of antioxidative-oxidative system in rats’ brain after 3 and 6 weeks of
experiment. Values presented as a median, minimum and maximum of examined parameters
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rats exposed to 500 mg Mn/L after 3 weeks of exposure.
Interestingly, the effect of glutamine co-administration is
observable after 6 weeks of experiment—lipid peroxida-
tion in groups of rats receiving Mn ? Gln is significantly
lower than in the groups of animals receiving metal alone.
Previous observation revealed that the administration of
glutamine completely prevented the increase in thiobarbi-
turic acid reactive substances (TBARS) content in rats’
liver treated with cobalt [31, 37].
Ascorbic acid, a non-enzymatic antioxidant, is found in
high concentrations in the brain and is an essential vitamin
for its physiological functions [38]. Zhang et al. [25]
studies showed that the ascorbic acid prevents the pro-
duction of ROS in mitochondrial preparations caused by
high doses of manganese. According to these authors,
ascorbic acid donates hydrogen atom to the hydroxyl rad-
icals, singlet oxygen and peroxide and consequently causes
blocking of free radical chain reactions, particularly in
neurodegenerative diseases [39, 40]. However, in vitro
studies demonstrated vitamin C prooxidative properties—
ascorbic acid can generate the formation of free radicals by
Fenton reaction [41, 42]. Similar conclusions from an
in vivo study were put forward by Aydogan et al. [43].
These authors suggest that ascorbic acid can exert proox-
idant action (especially in the brain, which is rich in Fe2?
ions) leading to neurotoxicity. In our study no statistically
significant changes in the concentration of ascorbic acid,
irrespective of the dose and time of manganese intoxica-
tion, were stated. Therefore determination the influence of
manganese on the level of ascorbic acid in the brain is quite
difficult. However, during examination of the ascorbic acid
concentration in the brain, another mechanism of its action
(not only associated with its antioxidant activity) should be
considered. Ascorbic acid acts as antagonist in the gluta-
matergic and dopaminergic systems. It is released from
glutamatergic neurons in the glutamate reuptake process, in
which the glutamate transporter exchanges ascorbic acids
for glutamate [44]. The balance between glutamate and
ascorbic acids can regulate neuronal capability to degen-
eration. The increase of the glutamergic activity can result
in the accumulation of reactive oxygen species [39].
Brain Tissues Amino Acids
Manganese has been recently showed to exert effect on
neurotransmitter amino acids concentrations in the brain.
Obtained results depend on variety of different factors such
as the mode and time of exposure and the amount of the
applied dose of the metal. In vitro and in vivo studies
indicate that there is a relationship between excessive
accumulation of manganese versus fluctuation of GABA
concentration, although the results of these studies are
inconclusive [45–47]. Lipe et al. [45] noticed the increased
level of GABA, as well as of other neurotransmitters:
aspartate, glutamate and glutamine in the cerebellum of the
adults rats (90-day-old) exposed to 20 mg Mn/kg per day
for 30 days. Moreover, in this study, significant decrease in
the concentration of glutamine in caudate nucleus and
hippocampus of weanling (30-day-old) rats dosed with
10 mg/kg per day for 30 days was observed. However,
Bonilla et al. [48] observed no alterations in concentration
of GABA and other inhibitory and excitatory amino acids
in the striatum of mice treated with intraperitoneal Mn
injections (5 mg/kg body weight per day) during nine
weeks while reducing the contents of aspartate, glutamate,
GABA and glicyne in olfactory bulb. Santos et al. [46]
showed no effect of sub-chronic exposure to manganese
injection on GABA, Glu and Asp concentrations and
increase of Gly concentration in whole rats’ brain in this
condition. On the other hand, Takeda et al. [47] showed
that manganese reduces the level of glycine in the striatum
of rats injected with Mn. Santos et al. [46] explain their
findings that the concentration of these amino acids
determined in the entire brain masks changes in those areas
of the brain where amino acids accumulation is the greatest
(globus pallidus and the striatum). However, our research
has shown that the manganese toxicity causes changes in
the concentrations of neurotransmitters in whole rats’
brain. We noticed that higher dose of Mn after 3 weeks of
exposure caused a slight increase in the concentration of
Gly, Gln and Glu and reduction in the concentration of
GABA in comparison to the control. Administration of Mn
in 500 mg/L dose (alone or in combination with Gln)
resulted in an increase in Gly concentration. We presume
that Gly, as a precursor of GSH, can protect against Mn-
induced oxidative stress.
There are several explanations for the relationship
between manganese neurotoxicity and neurotransmitter
amino acids concentration in the brain. Glu and GABA are
the most abundant neurotransmitters in the brain and their
metabolism is closely related [49, 50]. Mn neurotoxicity
may be related to an indirect excitotoxic event caused by
the increased extracellular Glu levels. Bouabid et al. [49]
elucidates that Mn is concurrently released with Glu from
glutamatergic neuron terminals. Therefore, the hyperac-
tivity of corticostriatal neurons during Mn intoxication may
partially contribute to the elevated extracellular Glu levels.
Moreover, Mn may be stimulator of post-synaptic receptors
to Glu. In addition, this element excitotoxicity can result in
a reduced ability of astrocytes to clear Glu from the
synapse and Glu/aspartate transporter expression in these
cells what can lead to increased Glu concentration [49, 50].
Furthermore, several studies have demonstrated the ten-
dency of Mn to impair components of the glutamine/glu-
tamate-GABA cycle what leads to reduction in Glu uptake
and elevation in extracellular Glu level [11]. Gln is formed
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Fig. 3 Effect of manganese and/or glutamine on exicatory (Glu, Asp) and inhibitory (GABA, Gly) neurotransmitter amino acids concentrations
in rats’ brains after 3 and 6 weeks of experiment. Values presented as a median, minimum and maximum of examined parameters
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in Glu and ammonia reaction catalyzed by GS. The newly
formed glutamine is transferred from astrocytes to neigh-
bouring neurons and hydrolized by phosphate-activated
glutaminase (PAG) which results in a Glu formation. Part
of this Glu could undergo decarboxylation to GABA (using
glutamate decarboxylase, GAD), transamination to Asp or
it could be converted to the tricarboxylic acid (TCA) cycle
intermediate—a-ketoglutarate [12]. In turn, Glu released
from neurons can be transported to the astrocyte via glu-
tamate transporter, where it is amminated to Gln. This
creates a shuttling metabolic cycle defined as glutamine/
glutamate-GABA cycle (GGC) [51]. Several studies have
demonstrated the tendency of Mn to impairing components
of the GGC leading to reduction in Glu uptake and ele-
vation in extracellular Glu level [52].Thus, manganese
toxicity results in inhibition of GS activity, which can
cause decrease in neuronal energy level and synthesis of
glutamine diminish. Moreover, in the animal models, ROS
can inhibit GS resulting in the decrease of Gln synthesis
[15]. Finally, the result is leading to disturbances of Gln/
Glu-GABA cycle, elevation of Glu and the decrease of Gln
concentration. Although, in our study statistically signifi-
cant diminish concentration of Gln in Mn-treated groups in
comparison to the control was not observed.
Earlier studies have shown that dietary glutamine can be
taken into the brain, via the Na?-dependent N-transporta-
tion system, leading to the increase of Gln level in the brain
[52, 53]. This appears to have been confirmed in our
research which showed that exogenous glutamine can
elevate glutamine level in the rats’ brain. The observed
trend toward time-dependent GABA increase in brains of
Gln group suggests that exogenous glutamine does not
disrupt the Gln/Glu-GABA cycle, but after entrance to
neurons, it is directly deaminated by phosphate-activated
glutaminase (PAG) to glutamate, and then Glu is converted
by GAD to GABA.
Summary
In summary, the presented studies established that Mn,
depending on the dose and duration of exposure, generates
excessive production of ROS, which manifests itself in the
oxidative stress intensification. Consistently with increased
ROS production, we observed decrease in GPx and SOD
activity and increase in MDA level. Gln is effective in
reducing Mn-induced oxidative stress. The consequence of
reduction in ROS production is an increase in GPx activity
and reduction in MDA concentration observed in in Mn-
Gln co-treated groups of rats. Moreover, the presented
experiment indicates that manganese influences the con-
centration of neurotransmitters’ amino acids.
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